| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ba2c4156354c844d4a8883be561f00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62535d121700fafa34e4953c6938fa16 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-918 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9936945b8a14e9bb1ec46e99a34df06d |
| publicationDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011085002-A1 |
| titleOfInvention |
Serum spla2-iia as diagnosis marker for prostate and lung cancer |
| abstract |
Methods for diagnosing prostate cancer and lung cancer are disclosed. The methods include obtaining a biological sample from a subject, determining a level of serum secretory phospholipase A 2 -IIA in the biological sample, comparing the level of serum secretory phospholipase A 2 -IIA with a baseline level of serum secretory phospholipase A 2 -IIA, and diagnosing prostate cancer or lung cancer in the subject. An elevated level of serum secretory phospholipase A 2 -IIA as compared to the baseline level correlates to a positive diagnosis of prostate cancer or lung cancer in the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013139968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2641916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9637553-B2 |
| priorityDate |
2010-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |